1. Home
  2. ROMA vs CGTX Comparison

ROMA vs CGTX Comparison

Compare ROMA & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROMA
  • CGTX
  • Stock Information
  • Founded
  • ROMA 2018
  • CGTX 2007
  • Country
  • ROMA Hong Kong
  • CGTX United States
  • Employees
  • ROMA N/A
  • CGTX N/A
  • Industry
  • ROMA Savings Institutions
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROMA Finance
  • CGTX Health Care
  • Exchange
  • ROMA Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • ROMA 22.9M
  • CGTX 20.5M
  • IPO Year
  • ROMA 2024
  • CGTX 2021
  • Fundamental
  • Price
  • ROMA $3.08
  • CGTX $0.24
  • Analyst Decision
  • ROMA
  • CGTX Strong Buy
  • Analyst Count
  • ROMA 0
  • CGTX 5
  • Target Price
  • ROMA N/A
  • CGTX $5.63
  • AVG Volume (30 Days)
  • ROMA 204.7K
  • CGTX 1.1M
  • Earning Date
  • ROMA 12-16-2024
  • CGTX 05-07-2025
  • Dividend Yield
  • ROMA N/A
  • CGTX N/A
  • EPS Growth
  • ROMA N/A
  • CGTX N/A
  • EPS
  • ROMA N/A
  • CGTX N/A
  • Revenue
  • ROMA $1,029,120.00
  • CGTX N/A
  • Revenue This Year
  • ROMA N/A
  • CGTX N/A
  • Revenue Next Year
  • ROMA N/A
  • CGTX N/A
  • P/E Ratio
  • ROMA N/A
  • CGTX N/A
  • Revenue Growth
  • ROMA N/A
  • CGTX N/A
  • 52 Week Low
  • ROMA $0.40
  • CGTX $0.22
  • 52 Week High
  • ROMA $3.25
  • CGTX $2.54
  • Technical
  • Relative Strength Index (RSI)
  • ROMA 88.74
  • CGTX 28.50
  • Support Level
  • ROMA $1.80
  • CGTX $0.22
  • Resistance Level
  • ROMA $2.09
  • CGTX $0.34
  • Average True Range (ATR)
  • ROMA 0.30
  • CGTX 0.03
  • MACD
  • ROMA 0.09
  • CGTX -0.01
  • Stochastic Oscillator
  • ROMA 88.67
  • CGTX 14.41

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: